Penn Medicine 2020 Updates in Oncology

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Penn Medicine 2020 Updates in Oncology

Videos
Event

Playback speed

10 seconds

Managing mNSCLC Patients With a Molecular Target: How Promising Are New RET & MET Inhibitors?

By Penn Medicine 2020 Updates in Oncology FEATURING Joshua Bauml

140 views

March 22, 2021

Comments 0

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Videos

Managing mNSCLC Patients: DFS Data on Adjuvant Osimertinib After Res…

Penn Medicine 2020 Updates in Oncology

J. Bauml

47 views

Managing mNSCLC Patients With a Molecular Target: How Promising Are …

Penn Medicine 2020 Updates in Oncology

J. Bauml

140 views

Myeloma Management Strategies: Efficacy Analysis of 1L Options & Ant…

Penn Medicine 2020 Updates in Oncology

D. Vogl

253 views

Emerging Data from 2020 ASCO Update: How Has SARS-CoV-2 Cancer Patie…

Penn Medicine 2020 Updates in Oncology

C. Aggarwal

17 views

COVID-19 Database Learnings and National Organization Responses: Wha…

Penn Medicine 2020 Updates in Oncology

L. Shulman

33 views

COVID-19 Thrombotic Manifestation Review: How Common Is VTE in ICU P…

Penn Medicine 2020 Updates in Oncology

A. Pishko

82 views

2020 ASCO Penn Medicine Update on Cancer Care During COVID-19: Which…

Penn Medicine 2020 Updates in Oncology

L. Schuchter

8 views

2020 ASCO Update on CLL: Does Time-limited Triplet Therapy Induce Ra…

Penn Medicine 2020 Updates in Oncology

J. Gerson

274 views

2020 ASCO Update on Lymphomas: Should Pembro Be New SoC in R/R cHL? …

Penn Medicine 2020 Updates in Oncology

J. Gerson

249 views

ASCO Update on MM: Does Selinexor Triplet vs. SoC Improve PFS? How t…

Penn Medicine 2020 Updates in Oncology

D. Vogl

115 views

ASCO Update on Myeloma: How Promising Are BCMA CAR-T & BCMA x CD3 Bi…

Penn Medicine 2020 Updates in Oncology

D. Vogl

136 views

2020 ASCO Update on mUC: Does the Earlier Use of a Switch Maintenanc…

Penn Medicine 2020 Updates in Oncology

V. Narayan

62 views

2020 ASCO Update on Prostate Cancer: How Effective Are Recently FDA …

Penn Medicine 2020 Updates in Oncology

V. Narayan

252 views

2020 ASCO Update on RCC: IO + TKIs - Is There Long-term Efficacy?

Penn Medicine 2020 Updates in Oncology

V. Narayan

24 views

2020 Update on MBC: Should Treatment of De Novo Disease Include Loco…

Penn Medicine 2020 Updates in Oncology

A. DeMichele

194 views

2020 Adjuvant Escalation and De-escalation in Early Stage BC: Is T-D…

Penn Medicine 2020 Updates in Oncology

A. DeMichele

712 views

2020 ASCO GI Cancer Update: Are CPIs Superior to 2nd Line Chemo in S…

Penn Medicine 2020 Updates in Oncology

J. Eads

453 views

2020 ASCO GI Cancer Update: Is There a Difference in Survival With F…

Penn Medicine 2020 Updates in Oncology

J. Eads

930 views

2020 ASCO CRC Update: Encorafenib and Cetuximab in BRAF V600 mCRC, I…

Penn Medicine 2020 Updates in Oncology

J. Eads

195 views

2020 ASCO Penn Medicine Breaking News: Anticoagulation Regimens Duri…

Penn Medicine 2020 Updates in Oncology

J. Bauml, P. Kumar, L. Schuchter, J. Eads, D. Mintzer, J. Gerson, A. Pishko

18 views